Ad copy

Join Our Clinical Research Trial Exploring Fatty Liver Disease We are conducting a clinical research trial to test an investigational medicine for people with a liver condition known as metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis. This study aims to determine how effective and safe this investigational medicine is for treating MASH. What is Metabolic Dysfunction-Associated Steatohepatitis (MASH)? MASH is a type of liver disease where fat builds up in the liver, leading to inflammation and damage. This can cause fibrosis, which is the scarring of liver tissue. Over time, if left untreated, it can lead to more serious liver issues. Key Facts About Liver Disease • The Liver's Role: Your liver is vital for digestion, detoxifying your blood, and storing energy. • MASH: This condition occurs when the liver stores too much fat, causing inflammation and scarring. • Symptoms: Many people with MASH might not have symptoms initially, but over time it can lead to fatigue, pain in the upper right abdomen, and other complications. Who Can Participate? You may be eligible to join our clinical research trial if you meet the following criteria: • You are a male or non-pregnant female between the ages of 18 and 75. • You have a Body Mass Index (BMI) between 25 and 50 kg/m². • You are pre-diabetic, have Type 2 Diabetes, high blood pressure, and / or high cholesterol. Who Cannot Participate? You are not eligible for this study if you: • Have another chronic liver disease. • Have a history or current evidence of cirrhosis. • Have type 1 diabetes. Why Participate? By participating in this clinical research trial, you will be contributing to important research investigating treatments for MASH. What's in It for You? • Travel Reimbursement: Worried about the cost of getting to our clinic? We’ve got you covered for reasonable travel costs. How to Apply: To determine your eligibility for this clinical research trial, please fill out our online eligibility form.